Abstract
Introduction Prostate cancer (PCa) is the fourth most prevalent cancer globally, and the most common among men. Most PCa patients in Oman are presented during the advanced stages of the disease with widespread metastatic disease reducing their overall rates of survival. Characterisation of the Omanis PCa population could be beneficial to develop a clinical profile demonstrating specific characteristics to better classify and derive radiomics signatures. These could help in developing artificial intelligence methods to assist with earlier and quicker diagnosis of possible prostate lesions.
Methods A retrospective, cross-sectional study has been designed to determine the pathological and radiological characteristics based on multi-sequence 3-dimensional Magnetic Resonance Imaging (MRI). The MRI records are maintained within the existing electronic healthcare records of the Sultan Qaboos University Hospital’s Department of Radiology and Molecular Imaging. Data will be extracted based on a confirmed diagnosis reported between the 1st of January 2010 and October 2023. All patients included within the study will be aged between 18-99 years. A study specific data extraction template has been devised to gather demographic details, clinical parameters and radiological findings based on existing imaging reports within the HIS and PACS systems.
Ethics approval Research Ethics approval reference for this study is (MREC #3176 REF. NO. SQU-EC/ 283\2023)
Conclusion The data analysis will be conducted using statistical software to conduct a Joinpoint regression analysis and linear regression modelling. We will also conduct a descriptive analysis.
- Prostate cancer
- Middle-Eastern population
- Clinical Epidemiology
- Artificial intelligence
- Radiomics
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Sultan Quaboos University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵** Shared first author
FUNDING STATEMENT An internal grant from the College of Medicine and Health Sciences at Sultan Qaboos University will be applied for, for the purpose of conducting this study.
COMPETING INTERESTS STATEMENT YB is applying for funding from the College of Medicine and Health Sciences at Sultan Qaboos University. GD has received funding from the National Institute for Health Research. PP has received a research grant from Novo Nordisk, JQS received funding from Shenzhen Fundamental Research Program and other, educational from the Queen Mary University of London, other from John Wiley & Sons, other from Otsuka, other from Janssen, outside the submitted work. All other authors report no conflict of interest. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or the Academic institutions.
DATA AVAILABILITY STATEMENT The authors will consider sharing the datasets gathered upon receipt of reasonable requests.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
